These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38534214)

  • 1. Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo.
    O'Neill AF; Nguyen EM; Maldonado ED; Chang MR; Sun J; Zhu Q; Marasco WA
    Antibodies (Basel); 2024 Mar; 13(1):. PubMed ID: 38534214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
    O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
    Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
    Manara MC; Manferdini C; Cristalli C; Carrabotta M; Santi S; De Feo A; Caldoni G; Pasello M; Landuzzi L; Lollini PL; Salamanna F; Dominici S; Fiori V; Magnani M; Lisignoli G; Scotlandi K
    Cancer Immunol Res; 2024 Feb; 12(2):247-260. PubMed ID: 38051221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
    Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
    Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
    Balestra T; Manara MC; Laginestra MA; Pasello M; De Feo A; Bassi C; Guerzoni C; Landuzzi L; Lollini PL; Donati DM; Negrini M; Magnani M; Scotlandi K
    Mol Cancer Ther; 2022 Jan; 21(1):58-69. PubMed ID: 34667115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
    Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
    Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
    Balaraman K; Deniz E; Nelson E; Pilicer SL; Atasoy S; Molotkova A; Sevim H; Tiwari PB; Üren A; Wolf C
    Eur J Med Chem; 2023 May; 251():115244. PubMed ID: 36917882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
    Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
    Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD99 at the crossroads of physiology and pathology.
    Pasello M; Manara MC; Scotlandi K
    J Cell Commun Signal; 2018 Mar; 12(1):55-68. PubMed ID: 29305692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDF6-CD99 Signaling Regulates Src and Ewing Sarcoma Growth.
    Zhou F; Elzi DJ; Jayabal P; Ma X; Chiu YC; Chen Y; Blackman B; Weintraub ST; Houghton PJ; Shiio Y
    Cell Rep; 2020 Nov; 33(5):108332. PubMed ID: 33147457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation.
    De Feo A; Sciandra M; Ferracin M; Felicetti F; Astolfi A; Pignochino Y; Picci P; Carè A; Scotlandi K
    Cell Death Dis; 2019 Jun; 10(7):471. PubMed ID: 31209202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
    Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
    J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
    Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
    Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.
    Sevim H; Çelik H; Düşünceli L; Ceyhan CS; Molotkova A; Nakazawa K; Graham GT; Petro JR; Toretsky JA; Üren A
    PLoS One; 2021; 16(6):e0253170. PubMed ID: 34133426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation NKX2.2 IHC and
    Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
    Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.
    De Feo A; Manfredi M; Mancarella C; Maqueda JJ; De Giorgis V; Pignochino Y; Sciandra M; Cristalli C; Donadelli M; Scotlandi K
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338867
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Louati S; Senhaji N; Chbani L; Bennis S
    Dis Markers; 2018; 2018():7971019. PubMed ID: 30319719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation.
    Hesketh AJ; Maloney C; Behr CA; Edelman MC; Glick RD; Al-Abed Y; Symons M; Soffer SZ; Steinberg BM
    PLoS One; 2015; 10(12):e0145197. PubMed ID: 26709919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.